These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32643500)

  • 1. Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors.
    Yankelevich M; Hoogstra DJ; Abrams J; Chu R; Bhambhani K; Taub JW
    Pediatr Hematol Oncol; 2020 Nov; 37(8):665-675. PubMed ID: 32643500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.
    Meisenberg BR; Davis TA; Melaragno AJ; Stead R; Monroy RL
    Blood; 1992 May; 79(9):2267-72. PubMed ID: 1373969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
    Cairo MS; Shen V; Krailo MD; Bauer M; Miser JS; Sato JK; Blatt J; Blazar BR; Frierdich S; Liu-Mares W; Reaman GH
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):30-8. PubMed ID: 11196267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
    Lydaki E; Bolonaki E; Stiakaki E; Dimitriou H; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1995; 12(6):551-8. PubMed ID: 8589000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
    Kushner BH; Heller G; Kramer K; Cheung NK
    Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF in solid tumor chemotherapy: a tailored regimen reduces febrile neutropenia, treatment delays and direct costs.
    Tsavaris N; Kosmas C; Gouveris P; Vadiak M; Dimitrakopoulos A; Karadima D; Pagouni E; Panagiotakopoulos G; Tzima E; Ispoglou S; Sakelariou D; Koufos C
    Med Sci Monit; 2004 Feb; 10(2):PI24-8. PubMed ID: 14737055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics.
    Yankelevich M; Goodell MA; Kaplan J
    Exp Hematol; 2008 Jan; 36(1):9-16. PubMed ID: 17949891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer.
    Rahiala J; Perkkiö M; Riikonen P
    Med Pediatr Oncol; 1999 May; 32(5):326-30. PubMed ID: 10219332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
    Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
    Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.
    García-Carbonero R; Mayordomo JI; Tornamira MV; López-Brea M; Rueda A; Guillem V; Arcediano A; Yubero A; Ribera F; Gómez C; Trés A; Pérez-Gracia JL; Lumbreras C; Hornedo J; Cortés-Funes H; Paz-Ares L
    J Natl Cancer Inst; 2001 Jan; 93(1):31-8. PubMed ID: 11136839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT.
    Kawano Y; Takaue Y; Mimaya J; Horikoshi Y; Watanabe T; Abe T; Shimizu Y; Matsushita T; Kikuta A; Watanabe A; Iwai A; Ito E; Endo M; Kodani N; Ohta S; Gushi K; Azuma H; Etoh T; Okamoto Y; Amano K; Hattori H; Eguchi H; Kuroda Y
    Blood; 1998 Dec; 92(11):4040-6. PubMed ID: 9834207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).
    Scherrer R; Geissler K; Kyrle PA; Gisslinger H; Jäger U; Bettelheim P; Laczika K; Locker G; Scholten C; Sillaber C
    Ann Hematol; 1993 Jun; 66(6):283-9. PubMed ID: 7686404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed commencement of granulocyte colony-stimulating factor following autologous bone marrow transplantation accelerates neutrophil recovery and is cost-effective.
    Clark RE; Shlebak AA; Creagh MD
    Leuk Lymphoma; 1994 Dec; 16(1-2):141-6. PubMed ID: 7535142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
    Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal timing (Preemptive versus supportive) of granulocyte colony-stimulating factor administration following high-dose cyclophosphamide.
    Koumakis G; Vassilomanolakis M; Barbounis V; Hatzichristou E; Demiri S; Plataniotis G; Pamouktsoglou F; Efremidis AP
    Oncology; 1999; 56(1):28-35. PubMed ID: 9885374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy-induced neutropenia.
    Saarinen UM; Hovi L; Riikonen P; Pihkala J; Juvonen E
    Med Pediatr Oncol; 1992; 20(6):489-96. PubMed ID: 1435519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.